Inj, tocilizumab-anoh, hospi
Full descriptor
Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
Details
- Code
- Q0237
- Short descriptor
- Inj, tocilizumab-anoh, hospi
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Jan 24 2025
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Inj, tocilizumab-aazg, hospi
Inj, monoclon antibody, 1 mg
Inj, tocilizumab-bavi, 1mg
Tocilizumab for covid-19
Inj, pemivibart, 4500 mg
Unspecified oral anti-emetic
Dolasetron mesylate oral
Hydroxyzine pamoate 25mg
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.